TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
TumCP↓, Casp3↑, EGFR↓, HER2/EBBR2↓, ERK↓, Apoptosis↑,
| - |
in-vitro, |
Colon, |
CCl233 |
|
|
|
TumCP↓, PARP↓, VEGF↓,
| - |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
CT26 |
|
|
|
TumCP↓, TumCMig↑, TumCI↑, EMT↑, MMP2↓, MMP9↑, STAT3↑, TumMeta↑, ROS↑,
ROS↓, Inflam↓, TumCP↓, Apoptosis↑, *Dose↝, *BioAv↓, *BioAv↑, GSH↑, GSTs↑, PGE2↓, COX1↑, IL8↓, COX2↓, iNOS↓, NF-kB↓, chemoP↑,
TumCP↓, cycD1/CCND1↓, Apoptosis↑, PI3K↓, Akt↓, ROS↑, Casp3↑, Cyt‑c↑, Bcl-2↓, TumCCA↑, Dose∅, ALP↓, LDH↓, PCNA↓, P53↑, Bax:Bcl2↑,
NRF2↑, TumCP↓, mt-ROS↓, Keap1↓,
| - |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
TumCP↓, TumCMig↓, TumCCA↑, Apoptosis↑, ATM↑, Chk2↑, ATR↑, CHK1↑, CK2↓, cycA1/CCNA1↑, CDK4↓, CDK6↓, cycD1/CCND1↓, cycE/CCNE↓, P53↑, P21↑,
HH↓, Smo↓, TumCP↓, Apoptosis↑,
| - |
in-vitro, |
Colon, |
HT-29 |
|
|
|
- |
in-vitro, |
Colon, |
SW48 |
|
|
|
TumCCA↑, p27↑, cycD1/CCND1↓, TumCP↓, IGF-1R↓, Akt↓, Wnt↓, P53↑, Apoptosis↑, Sp1/3/4↓, cl‑PARP↑, β-catenin/ZEB1↓, MDM2↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↑, 1, GSTs↑, 1, Keap1↓, 1, NRF2↑, 1, ROS↓, 1, ROS↑, 2, mt-ROS↓, 1,
Core Metabolism/Glycolysis ⓘ
LDH↓, 1,
Cell Death ⓘ
Akt↓, 2, Apoptosis↑, 6, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp3↑, 2, Chk2↑, 1, CK2↓, 1, Cyt‑c↑, 1, iNOS↓, 1, MDM2↓, 1, p27↑, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1, Sp1/3/4↓, 1,
DNA Damage & Repair ⓘ
ATM↑, 1, ATR↑, 1, CHK1↑, 1, P53↑, 3, PARP↓, 1, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycA1/CCNA1↑, 1, cycD1/CCND1↓, 3, cycE/CCNE↓, 1, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
EMT↑, 1, ERK↓, 1, HH↓, 1, IGF-1R↓, 1, PI3K↓, 1, Smo↓, 1, STAT3↑, 1, Wnt↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↑, 1, TumCI↑, 1, TumCMig↓, 1, TumCMig↑, 1, TumCP↓, 9, TumMeta↑, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↑, 1, COX2↓, 1, IL8↓, 1, Inflam↓, 1, NF-kB↓, 1, PGE2↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
Dose∅, 1,
Clinical Biomarkers ⓘ
ALP↓, 1, EGFR↓, 1, HER2/EBBR2↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
chemoP↑, 1,
Total Targets: 65
Pathway results for Effect on Normal Cells:
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, Dose↝, 1,
Total Targets: 3
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page